Optos PLC

Optos PLC of Dunfermline, UK, has received FDA approval for its P200MA retinal imaging device. The instrument, which takes a quarter of a second to scan approximately 80 percent of the retina, is expected to aid in the detection of glaucoma, diabetes and high blood pressure, among other diseases. The technology is already being tested in the US.





LATEST NEWS

• CLEO Heads to the East Coast
  Apr 29, 2024
• Laser-Based Gas Analyzer Developed to Detect Air Pollution
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024
• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024